2021 annual financial data
Cytek Biosciences, Inc. 2021 Operating margin
Cytek Biosciences, Inc. 2021 operating margin with verified reported values.
Direct answer
Operating margin was 7.16%.
Operating income was 9,157,000 USD and net income was 3,001,000 USD.
Operating cash flow was 4,630,000 USD.
Get free Cytek Biosciences, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 127,950,000 USD
- Operating income
- 9,157,000 USD
- Net income
- 3,001,000 USD
- Operating cash flow
- 4,630,000 USD